The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrations
Article in European Journal of Cancer (March 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in European Journal of Cancer (March 2024)
Article in Pharmaceuticals (February 2024)
Article in Cancer Genomics & Proteomics (December 2023)